Mydecine is planning to spin out its U.S. legacy cannabis assets.
INVESTOR PROFILE | Ionic Brands
Company:
Ionic Brands
Symbol:
CSE: IONC
Country:
United States
Sector:
Legal Recreational Marijuana
Industry:
Concentrates and Vapes
Established:
2015
Website:
Company:
Ionic Brands
Symbol:
CSE: IONC
Country:
United States
Sector:
Legal Recreational Marijuana
Industry:
Concentrates and Vapes
Established:
2015
Website:
52-Week
Range N/A
Range N/A
Current
Outstanding 108,436,715
Outstanding 108,436,715
Warrants
Options
Fully Diluted
Market Cap.
14,639,000
14,639,000
IONIC BRANDS (CSE: IONC) has a premium portfolio of cannabis concentrate consumer brands. Ionic Brands is one of the top selling concentrate company in Washington State.
Company Brief
Ionic Brands (CSE: IONC) is creating a multi-state, consumer focused, premium cannabis porfolio consisting of iconic national brands.
They have:
- Stylish products
- World Class Management Team
- A proven and repeatable strategy for success
Highlights
Experienced and proven luxury cannabis concentrates brand
One of the tops selling vape brands in WA State with a loyal customer base
Largest standalone oil manufacturer in the state of WA
Consistent sales growth over 3 years with a verified marketing blueprint
Offers investors exposure to a premium luxury cannabis brand
Demonstrated to have a winning formula to become the top vape company in WA
Massive growth opportunity available with expansion into OR, NV and CA
In The News
Ionic Is Changing the Face of Cannabis and Creating a Social Revolution
It’s all in the URL: Ionic.social. “We believe our products are best when enjoyed in a social setting,” said co-founder Christian Struzan.
READ MORE
Marijuana Vaping Is The Most Explosive Growth Play In Marijuana Today
“Nobody smokes marijuana anymore, they vape it.” - New York Times That's not quite true. But it will be soon.
READ MORE
How To Invest In Marijuana Vaping
The marijuana vaporization products (or just "vape") market is set to explode in 2019.
READ MORE
Related Articles
Compass Pathways Raising Up To $107.2 million For IPO, Valuation $500+ Million
Compass Pathways has set the terms for its IPO, targeting a valuation at or about $544.1 million.
Martha Stewart Launching CBD Line with Canopy Growth
Martha Stewart has partnered with Canopy Growth on a CBD product line set for a release this week after more than a year in development, CNNreports. The products will be sold online via the Canopy website and will range from $34.99 to $44.99 with a line of pet products set for later this year.
Vermont House Approves Marijuana Expungement And Decriminalization Expansion Bill
The Vermont House gave preliminary approval on Friday to a bill that would provide for automatic expungements of marijuana convictions and allow people to possess and grow more cannabis without the threat of jail time than is currently allowed.
Bill To Regulate CBD As A Dietary Supplement Introduced In Congress
A bill that would allow CBD derived from hemp to be sold as a dietary supplement was introduced in the House of Representatives last week in a bid to jumpstart an industry hampered by inaction from the U.S. Food and Drug Administration (FDA).
Is Psilocybin More Revolutionary Than Spravato for Depression?
Spravato has not been the "game-changer" for treating depression that it was touted as being. The market remains wide open for psilocybin (and other psychedelics).